| By: |
Eleftherios Sapsalis (Centre Emile Bernheim, Solvay Business School, Université Libre de Bruxelles, Brussels);
Bruno Van Pottelsberghe (Centre Emile Bernheim, Solvay Business School, Université Libre de Bruxelles, Brussels);
Ran Navon (Solvay Business School, Université Libre de Bruxelles, Brussels) |
| Abstract: |
This paper compares corporate and academic patents in order to test whether
the sectors apply for patents with similar values and similar determinants of
value. The determinants of patent value are mainly related to the
identification of institutional sources of knowledge. The results show that :
(i) the value distributions show a similar skewness for both corporate and
academic patents; (ii) the determinants of patent value are broadly similar,
except for incremental inventions arising from the academic sector; (iii)
co-applications with other public institutions is worth it only for
universities. The policy implications suggested by these results are the
positive impact of collaborative R&D, and the need to focus on researchers
with a high scientific profile in terms of publications in order to
crystallize their scientific expertise -or tacit knowledge- into high value
patents. These conclusions hold for both the academic and corporate sectors. |
| Keywords: |
Patent value, biotechnology, academic patenting. |
| JEL: |
L33 O33 O34 |
| Date: |
2005–07 |
| URL: |
http://d.repec.org/n?u=RePEc:sol:wpaper:05-008&r=sog |